Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve

JACC: Cardiovascular Interventions

Volumn 9, Issue 3, 2016, Pages 244-254

  Husser, Oliver ^a   Pellegrini, Costanza ^a   Kessler, Thorsten ^a   Burgdorf, Christof ^a   Thaller, Hannah ^a   Mayr, N Patrick ^a   Kasel, Albert M ^a   Kastrati, Adnan ^a,b   Schunkert, Heribert ^a,b   Hengstenberg, Christian ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

conduction abnormalities; permanent pacemaker implantation; predictors; transcatheter aortic valve replacement

Indexed keywords

AGED; ANGIOGRAPHY; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIAL FIBRILLATION; BALLOON EXPANDABLE TRANSCATHETER HEART VALVE; BRADYCARDIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONSCIOUS SEDATION; ELECTROCARDIOGRAPHY; EUROSCORE; FEMALE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VALVE PROSTHESIS; HEART VENTRICLE CONDUCTION; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PACEMAKER IMPLANTATION; PRIORITY JOURNAL; QRS INTERVAL; VERY ELDERLY; ADVERSE EFFECTS; AORTIC VALVE; BUNDLE-BRANCH BLOCK; DIAGNOSTIC IMAGING; PROCEDURES; PROSPECTIVE STUDY; PROSTHETIC FITTING; STATISTICS AND NUMERICAL DATA; SURGERY; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED, 80 AND OVER; AORTIC VALVE; ATRIAL FIBRILLATION; BRADYCARDIA; BUNDLE-BRANCH BLOCK; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; PROSTHESIS FITTING; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84977661304     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.09.036     Document Type: Article

References (32)

1. 1 Franzoni, I., Latib, A., Maisano, F., et al. Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve. Am J Cardiol 112 (2013), 554–559.
2. 2 Urena, M., Mok, M., Serra, V., et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol 60 (2012), 1743–1752.
3. 3 Houthuizen, P., van der Boon, R.M., Urena, M., et al. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention 9 (2014), 1142–1150.
4. 4 Nazif, T.M., Williams, M.R., Hahn, R.T., et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J 35 (2014), 1599–1607.
5. 5 Urena, M., Webb, J.G., Cheema, A., et al. Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol Intv 7 (2014), 128–136.
6. 6 Eltchaninoff, H., Prat, A., Gilard, M., et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 32 (2011), 191–197.
7. 7 Leon, M.B., Smith, C.R., Mack, M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363 (2010), 1597–1607.
8. 8 Siontis, G.C., Jüni, P., Pilgrim, T., et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 64 (2014), 129–140.
9. 9 Buellesfeld, L., Stortecky, S., Heg, D., et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol 60 (2012), 493–501.
10. 10 Urena, M., Webb, J.G., Tamburino, C., et al. Permanent pacemaker implantation following transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation 129 (2013), 1233–1243.
11. 11 Chevreul, K., Brunn, M., Cadier, B., et al. Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Arch Cardiovasc Dis 106 (2013), 209–219.
12. 12 Tops, L.F., Schalij, M.J., Bax, J.J., The effects of right ventricular apical pacing on ventricular function and dyssynchrony: implications for therapy. J Am Coll Cardiol 54 (2009), 764–776.
13. 13 Hoffmann, R., Herpertz, R., Lotfipour, S., et al. Impact of a new conduction defect after transcatheter aortic valve implantation on left ventricular function. J Am Coll Cardiol Intv 5 (2012), 1257–1263.
14. 14 Tzikas, A., van Dalen, B.M., Van Mieghem, N.M., et al. Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction. Am J Cardiol 107 (2011), 285–289.
15. 15 Binder, R.K., Rodés-Cabau, J., Wood, D.A., et al. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. J Am Coll Cardiol Intv 6 (2013), 293–300.
16. 16 Webb, J., Gerosa, G., Lefèvre, T., et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol 64 (2014), 2235–2243.
17. 17 Tarantini, G., Mojoli, M., Purita, P., et al. Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. EuroIntervention 11 (2015), 343–350.
18. 18 Murray, M.I., Geis, N., Pleger, S.T., et al. First experience with the new generation Edwards SAPIEN 3 aortic bioprosthesis: procedural results and short term outcome. J Interv Cardiol 28 (2015), 109–116.
19. 19 Achenbach, S., Delgado, V., Hausleiter, J., Schoenhagen, P., Min, J.K., Leipsic, J.A., SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr 6 (2012), 366–380.
20. 20 Holzamer, A., Sitka, E., Hengstenberg, C., et al. Multislice computed tomography-based prediction of the implantation plane in transcatheter aortic valve implantation: determination of the line of perpendicularity and the implanter's views†. Eur J Cardiothorac Surg 48 (2015), 879–886.
21. 21 Kasel, A.M., Cassese, S., Leber, A.W., von Scheidt, W., Kastrati, A., Fluoroscopy-guided aortic root imaging for TAVR: follow the right cusp rule. J Am Coll Cardiol Img 6 (2013), 274–275.
22. 22 Surawicz, B., Childers, R., Deal, B.J., et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. J Am Coll Cardiol 53 (2009), 976–981.
23. 23 Kappetein, A.P., Head, S.J., Généreux, P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 60 (2012), 1438–1454.
24. 24 Husser, O., Kessler, T., Burgdorf, C., et al. Conduction abnormalities and pacemaker implantations after SAPIEN 3 vs SAPIEN XT prosthesis aortic valve implantation. Rev Esp Cardiol (Engl Ed), 2015 Nov 2 [E-pub ahead of print].
25. 25 Roten, L., Wenaweser, P., Delacrétaz, E., et al. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol 106 (2010), 1473–1480.
26. 26 Aktug, Ö., Dohmen, G., Brehmer, K., et al. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation. Int J Cardiol 160 (2012), 26–30.
27. 27 van der Boon, R.M., Houthuizen, P., Urena, M., et al. Trends in the occurrence of new conduction abnormalities after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 85 (2015), E144–E152.
28. 28 Willson, A.B., Webb, J.G., Labounty, T.M., et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol 59 (2012), 1287–1294.
29. 29 Yang, T.H., Webb, J.G., Blanke, P., et al. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. J Am Coll Cardiol Intv 8 (2015), 462–471.
30. 30 Schroeter, T., Linke, A., Haensig, M., et al. Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation. Europace 14 (2012), 1759–1763.
31. 31 Bleiziffer, S., Ruge, H., Hörer, J., et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. J Am Coll Cardiol Intv 3 (2010), 524–530.
32. 32 Binder, R.K., Webb, J.G., Toggweiler, S., et al. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. J Am Coll Cardiol Intv 6 (2013), 462–468.